News & Updates

COVID-19 vaccine safe to administer in first trimester of pregnancy, study says

21 Aug 2024

Among pregnant women, exposure to mRNA COVID-19 vaccine in the first trimester does not appear to contribute to an increased risk of selected major structural birth defects, according to a retrospective study.

COVID-19 vaccine safe to administer in first trimester of pregnancy, study says

21 Aug 2024

Rucaparib maintains PFS benefit at 4 years in stage III/IV ovarian cancer

20 Aug 2024 by

Treatment with rucaparib in patients with newly diagnosed advanced ovarian cancer provides long-term improvements in progression-free survival (PFS) both in those with high and low risk of disease progression, as shown in the updated PFS analyses of the ATHENA-MONO study.

Rucaparib maintains PFS benefit at 4 years in stage III/IV ovarian cancer

20 Aug 2024

Is long-acting cabotegravir safe as PrEP for expecting mothers?

20 Aug 2024 by

The use of long-acting injectable cabotegravir (CAB-LA) as a pre-exposure prophylaxis (PrEP) during pregnancy appears to be safe and well tolerated in cisgender women, according to the initial data of HPTN* 084 open-label extension (OLE) study presented at AIDS 2024.

Is long-acting cabotegravir safe as PrEP for expecting mothers?

20 Aug 2024

Dual-indication bivalent RSV vaccine now available in HK: Maternal immunization data

20 Aug 2024

Respiratory syncytial virus (RSV) prefusion F protein–based (RSVpreF) vaccine, a single-dose bivalent vaccine against RSV A and RSV B, is now available in Hong Kong for prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth up to 6 months of age through active immunization of pregnant individuals at a gestational age of 32–36 weeks, and for prevention of LRTD caused by RSV in individuals aged ≥60 years.

Dual-indication bivalent RSV vaccine now available in HK: Maternal immunization data

20 Aug 2024

Chemo plus atezolizumab improves survival while preserving life quality in advanced EC

19 Aug 2024 by

Treatment with carboplatin-paclitaxel (CP) plus atezolizumab results in better quality-adjusted survival in patients with advanced or recurrent endometrial cancer (EC) as compared with CP alone, according to a post hoc analysis of the AtTEnd/ENGOT-EN7 trial.

Chemo plus atezolizumab improves survival while preserving life quality in advanced EC

19 Aug 2024

Pre-eclampsia poses risk of vascular dementia

19 Aug 2024

Women who experience pre-eclampsia during pregnancy face a heightened risk of vascular dementia later in life, according to the results of a meta-analysis.

Pre-eclampsia poses risk of vascular dementia

19 Aug 2024

Epilepsy ups maternal, perinatal risks in pregnant women

14 Aug 2024

Pregnant women with epilepsy face considerably greater risk of severe morbidity as well as maternal and perinatal mortality, according to a study.

Epilepsy ups maternal, perinatal risks in pregnant women

14 Aug 2024

Early birth control pill use a red flag for endometriosis

10 Aug 2024

Young women who start taking hormonal contraceptives early in life may be at increased risk of endometriosis, as suggested in a study.

Early birth control pill use a red flag for endometriosis

10 Aug 2024

STI rates in high-risk populations curbed with doxycycline PrEP

09 Aug 2024 by

Pre-exposure prophylaxis (PrEP) with the antibiotic doxycycline helps to prevent sexually transmitted infections (STIs) in high-risk populations, including female sex workers and HIV-positive men who have sex with men (MSM), according to two small studies.

STI rates in high-risk populations curbed with doxycycline PrEP

09 Aug 2024

Pre-existing diabetes a risk factor for stillbirth, perinatal mortality

08 Aug 2024

Pre-existing diabetes has been linked to threefold greater odds of stillbirth and perinatal mortality, with type 2 posing a greater threat than type1 diabetes, according to the results of the meta-analysis.

Pre-existing diabetes a risk factor for stillbirth, perinatal mortality

08 Aug 2024

News & Updates

Filter by Specialty:

Specialty:

COVID-19 vaccine safe to administer in first trimester of pregnancy, study says

COVID-19 vaccine safe to administer in first trimester of pregnancy, study says

Rucaparib maintains PFS benefit at 4 years in stage III/IV ovarian cancer

Rucaparib maintains PFS benefit at 4 years in stage III/IV ovarian cancer

Is long-acting cabotegravir safe as PrEP for expecting mothers?

Is long-acting cabotegravir safe as PrEP for expecting mothers?

Dual-indication bivalent RSV vaccine now available in HK: Maternal immunization data

Dual-indication bivalent RSV vaccine now available in HK: Maternal immunization data

Chemo plus atezolizumab improves survival while preserving life quality in advanced EC

Chemo plus atezolizumab improves survival while preserving life quality in advanced EC

Pre-eclampsia poses risk of vascular dementia

Pre-eclampsia poses risk of vascular dementia

Epilepsy ups maternal, perinatal risks in pregnant women

Epilepsy ups maternal, perinatal risks in pregnant women

Early birth control pill use a red flag for endometriosis

Early birth control pill use a red flag for endometriosis

STI rates in high-risk populations curbed with doxycycline PrEP

STI rates in high-risk populations curbed with doxycycline PrEP

Pre-existing diabetes a risk factor for stillbirth, perinatal mortality

Pre-existing diabetes a risk factor for stillbirth, perinatal mortality